Advancing South Asian Cardiovascular Health

An In-Person & Virtual International CE accredited Conference Focusing on South Asian Heart Health


About the Conference

The international conference will bring together the voices of world-renowned experts in the field as well as patients and community members who live with heart disease in an efort to understand how collaborative decision-making can help improve heart health outcomes in South Asians in the United States. South Asians are among the fastest growing ethnic groups in the US, and show high rates of heart disease, as compared to other populations. With not enough research to examine their unique risks and develop effective ways to manage and care for their disease.

South Asians (SA) are among the fastest growing racial/ethnic groups in the US and bear a highly disproportionate burden of cardiovascular disease (CVD). SAs have the highest CVD rates among all racial/ethnic groups in the US, with a significantly higher prevalence of coronary artery disease (CAD), type 2 diabetes, hypertension, and a higher percentage of body fat than other immigrant groups and whites. Also, SAs tend to develop CAD at a younger age, often before 40 in men, and are more likely to die from CAD than other ethnic groups.

SAs in the US have few established resources related to their high risk for CVD, with significant implications for their health and well-being. Poor CVD outcomes management in SAs may be due to a lack of culturally and linguistically appropriate education materials for patients, inadequate patient knowledge of the healthcare system, lack of health insurance, and other social determinants - an area of further research. This diverse population also often faces tremendous cultural, socioeconomic, linguistic, and structural obstacles to achieving good health. Compounding these challenges, there is a dearth of detailed data on the unique risks, etiologic mechanisms, and effective interventions for CVD in first- and second-generation SAs in the US. This can lead to sub-optimal management of CVD, its risk factor modification, and thus increased recurrent CAD events, exacerbating racial/ethnic disparities and increasing the economic burden of CVD in the US.

In order to begin reversing this knowledge deficit, providers, patients, and shareholders need to be able to 1) identify risk factors, including social determinants, 2) learn about CVD management from worldwide programs, 3) understand the value of research participation in establishing priorities for future work on managing CVD in SAs in the US.

This international conference on South Asian cardiovascular health is designed to provide a high-quality scientific forum in a collaborative environment, which will include patients and providers. Internationally renowned researchers and clinicians will lead sessions addressing CVD risk factors, barriers to management, the role of Big Data, community prevention strategies, and the state of South Asian cardiovascular health in the United States from the AHA, ADA, and NIH perspectives.

To sponsor and support our conference, please download the sponsorship package

Goals & Objectives
  • Improve identification of risk factors, including social determinants, of cardiovascular disease in South Asians to create a framework for strategies for prevention, early diagnosis, and targeted treatment
  • Exchange information from worldwide programs to understand and enhance cardiovascular disease management and post-acute care in South Asians
  • Establish a list of priorities for future work on managing cardiovascular disease in South Asians
Target Audience
This activity is designed for healthcare professionals, trainees, and students involved with or interested in the healthcare of South Asians. In addition, this activity will be beneficial for patients, families/caretakers, community leaders and members, and social institutions so they can learn how they can assist with promoting optimal health for this diverse population.
CE Accreditation

In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences, SKN Foundation, Eastern Virginia Medical School and Saint Peter’s University Hospital. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 10.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity is awarded 10.25 ANCC contact hours. Nurses should claim only those contact hours actually spent participating in the activity.

Physician Assistants: NCCPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Method of Participation
In order to meet the learning objectives and receive continuing education credits, participants are expected to formally register for the symposium, check in at the registration desk and attend the program each day (in-person)/watch the webcast, and complete an online evaluation at the conclusion of the program. A CE certificate will be emailed to participants upon completion of the online evaluation.

Conference Schedule

Advancing South Asian Cardiovascular Health: Understanding Unique Risk Factors and Health Needs to Promote Shared Decision-Making

September 16-17, 2022 | Hybrid Event: Hyatt Regency, New Brunswick, New Jersey + Virtual Option
Time Topic Speakers
DAY 1 – Friday, September 16, 2022
8:00 AM – 8:45 AM Registration/Breakfast/Exhibits N/A
8:45 AM – 9:00 AM Welcome/Introduction Dr. Sunita Dodani & Dr. Naveen Mehrotra
9:00 AM – 9:30 AM Keynote Speaker: CVD Epidemic in South Asians: An Introduction to Mysteries and Hypotheses, Old and New Dr. Raj Bhopal
9:35 AM–10:05 AM NIH Perspective: CV Health of South Asians in the United States Dr. Yuling Hong
10:10 AM–10:40 AM Impact of Large South Asian Community-Based Studies: Diabetes as a Risk Factor for CVD Dr. V. Mohan
10:40 AM – 10:55 AM Break/Exhibits
11:00 AM – 12:30 PM Panel: South Asian Patient & Family Voices Moderator: Dr. Aparna Kalbag
12:30 PM – 1:30 PM Lunch/Networking/Exhibits
1:30 PM – 2:00 PM ADA Perspective: CVD Health of South Asians Dr. Guillermo Umpierrez
2:05 PM – 2:35 PM Lipids and CVD Risk in South Asians Dr. Daniel Rader
2:35 PM – 2:50 PM Break/Exhibits
2:50 PM – 3:20 PM South Asian Diet and Hypertension Dr. Arun Chockalingam
3:25 PM – 3: 55 PM Relationship of Genetics & Obesity to CVD in South Asians Dr. Alka Kanaya
4:00 PM- 4:30 PM Q & A with Closing Remarks Dr. Sunita Dodani & Dr. Naveen Mehrotra
6:00 PM - Gala Reception Dinner (separate ticketed event)
DAY 2 – Saturday, September 17, 2022
8:00 AM – 8:45 AM Breakfast/Exhibits N/A
8:45 AM – 9:00 AM Welcome/Introduction Dr. Sunita Dodani & Dr. Naveen Mehrotra
9:00 AM – 9:40 AM Keynote Speaker: An International Approach to the Prevention of CVD in South Asians Dr. Salim Yusuf
9:45 AM – 10:15 AM AHA Perspective: CVD Health of South Asians Dr. Donald Lloyd-Jones
10:15 AM – 10:30 AM Break/Exhibits
10:30 AM – 12:00 PM Panel: Provider Perspectives on CVD Care in South Asians Moderator: Dr. Meena Murthy
12:00 PM – 1:00 PM Lunch/Networking/Exhibits
1:00 PM – 1:30 PM Use of Big Data & CVD Prevention in South Asians Dr. Latha Palaniappan
1:35 PM – 2:05 PM Heterogeneity of Risk Among Asians and South Asians and the Role of Imaging for SACVD Risk Assessment in South Asians Dr. Salim Virani
2:10 PM – 2:40 PM Prevention of CVD: Lessons from a Community-based Screening Program for South Asians Ashish Mathur
2:40 PM – 2:55 PM Break/Exhibits
2:55 PM – 3:30 PM Summary of Unique Health Needs and Shared Decision-Making for Improved CVD Outcomes Dr. Naveen Mehrotra & Dr. Sunita Dodani

The relevant financial relationships of all individuals who affect the content of continuing education activities and any discussion of off-label/investigational uses will be disclosed to the audience at the time of the activity.


Salim Yusuf, D.Phil, FRCPC, FRSC, O.C

Heart and Stroke Foundation/Marion W. Burke Chair in Cardiovascular Disease

Distinguished University Professor of Medicine, McMaster University, Ontario, Canada

Raj Bhopal, CBE, DSc (hon), MD, BSc, MBChB, MPH, FRCP(E), FFPH

Emeritus Professor of Public Health Edinburgh Migration, Ethnicity and Health Research Group, Usher Institute, Medical School, University of Edinburgh


Guillermo Umpierrez


President, Medicine & Science, American Diabetes Association

Professor of Medicine, Emory University School of Medicine;

Division of Endocrinology, Metabolism,

Chief of Diabetes and Endocrinology, Grady Health Systems,

Emory University School of Medicine, GA

Donald Lloyd-Jones


President, American Heart Association

Chair, Department of Preventive Medicine.

Eileen M. Foell Professor. Professor of Preventive Medicine

(Epidemiology), Medicine (Cardiology) and Pediatrics,

Northwestern University Feinberg School of Medicine, IL


Arun Chockalingam


Professor of Medicine and Global Health, University of Toronto

Professor and Advisor to the Dean on Global Health, Faculty of Health, York University, Toronto, Canada

Founding Director, Office of Global Health, NHLBI, NIH

Yuling Hong


Chief, Epidemiology Branch

Division of Cardiovascular Sciences


Alka Kanaya


Professor of Medicine, Epidemiology and Biostatistics, Division of General Internal Medicine, University of California, San Francisco (UCSF), CA

Co-Leader, Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study

Ashish Mathur

B.Tech, MS

Co- Founder & Executive Director, South Asian Heart Center, El Camino Hospital, Mountain View, CA

V. Mohan

MD, FRCP (London, Edinburgh, Glasgow & Ireland), PhD, DSc, D.c (Hon. Causa), FNASc, FASc, FNA, FACE, FACP, FTWAS, MACP, FRS (Edinburgh)

Chairman, Dr. Mohan’s Diabetes Specialities Centre of Excellence in Diabetes Care, Southern India President and Director, Madras Diabetes Research Foundation, Chennai, India

Latha Palaniappan


Professor of Medicine (Primary Care and Population Health), Stanford University School of Medicine, CA

Scientific Director, Precision Genomics and Pharmacogenomics in Primary Care, Stanford Division of Primary Care and Population Health

Faculty Co-Director, Stanford Biobank

Co-Founder and Co-Director, Center for Asian Health Research and Education (CARE), Stanford Medicine

Daniel J. Rader


Chief, Division of Translational Medicine and Human Genetics

Associate Director, Institute for Translational Medicine and Therapeutics

Director, Preventive Cardiovascular Program

Seymour Gray Professor of Molecular Medicine, Perelman School of Medicine, University of Pennsylvania, PA

Salim Virani


Professor in Cardiology and Cardiovascular Research

Director, Cardiovascular Disease Fellowship Training Program, Baylor College of Medicine, Houston, TX

Co-Director, VA Advanced Fellowship Program in Health Services Research & Development


Sunita Dodani MBBS (MD), FCPS, MSc, PhD, FAHA

Professor of Medicine, Department of Internal Medicine & Professor, School of Health Professions (SHP)

Eastern Virginia Medical School (EVMS), & Founding Director, EVMS-Sentara Healthcare Analytics and Delivery Science Institute (HADSI)

Founder and Chair, Health Equity Collaborative of Virginia

Board Member, American Heart Association- National Research Committee

Board Director, American Heart Association- Hampton Roads Chapter

Naveen Mehrotra, MD, MPH

Director, My Whole Child Pediatrics

Founder and Executive Director, SKN Foundation

Clinical Assistant Professor of Pediatrics, Rutgers-RWJ Medical School

Adjunct Assistant Professor, Rutgers-RWJ School of Public Health

Meena S. Murthy, MD, FACE

Chief, Division of Endocrinology, Nutrition and Metabolism

Director, Thyroid and Diabetes Center

Director, South Asian Institute and SKN South Asian Diabetes Center

Saint Peter’s University Hospital, New Brunswick, NJ

Registration Fees (in USD)

Healthcare Professional With CE credits $250 USD
Healthcare Trainee (student, resident, fellow) With CE credits $125 USD
Community Member $125 USD
With CE Credits $100 USD
No CE Credits $25 USD

Registration fee includes continuing education credits and course material; in-person registration also includes continental breakfasts, refreshment breaks and lunches. Registration can only be accepted through our secure on-line website through September 15, 2022. Registration will not be confirmed until payment is received. If payment is not received in time for the activity, SKN Foundation reserves the right to cancel the registration. Reduced, one-day tuition rates are not available.

To register, visit:

Cancellation Fee/Refund
A full refund, less a $25 cancellation fee, will be granted if notice is received no later than September 1, 2022. Refunds will not be issued for any cancellations received after September 1, 2022 and cannot be given for no shows. To cancel, please contact Sabuha by email at


Hyatt Regency
2 Albany St
New Brunswick, NJ 08901
Reservations at Hyatt Regency in New Brunswick, New Jersey can be made by calling (732) 873-1234 or visiting the Hyatt’s website online. Conference Room rates: $119 per night plus tax and fees can be found through our room block link

A discounted parking rate is available for conference attendees.

For additional program information, questions, or concerns, or if you require special arrangements to attend this activity, please contact Sabuha Qureshi-Din by phone at 908-671-1344 or by email at

The SKN Foundation reserves the right to modify the activity content, faculty and activities, and reserves the right to cancel this activity, if necessary. If the activity is canceled, liability is limited to the registration fee.

Collaborating Organization

About the Medical Society of New Jersey:

Founded in 1766, the Medical Society of New Jersey (MSNJ) is the oldest professional society in the United States. MSNJ has a mission to promote the betterment of the public health and the science and the art of medicine, to enlighten public opinion in regard to the problems of medicine, and to safeguard the rights of the practitioners of medicine. MSNJ represents all medical disciplines and serves as an advocate for patient and physician rights. Its members are dedicated to ensuring delivery of the highest quality medical care throughout New Jersey. For more information, visit

Sponsorship Information

To sponsor and support our conference, please download the sponsorship package